Management Change25 May 2026, 07:12 pm

Bliss GVS Pharma: Santosh Parab Term Ends as Independent Director

AI Summary

Mr. Santosh Parab (DIN: 01622988) has completed his second and final term as an Independent Director of Bliss GVS Pharma Ltd, ceasing to be a Director effective May 25, 2026. He was re-appointed on May 26, 2021, for a 5-year term. The company expressed gratitude for his contributions.

Key Highlights

Santosh Parab's term as Independent Director of Bliss GVS Pharma concludes on May 25, 2026.
Parab served two terms and was re-appointed on May 26, 2021.
He will also cease to be a member of the Committees from the same date.
Bliss GVS Pharma acknowledges Parab's valuable contribution during his tenure.

View BSE Filing

BLISSGVS

Pharmaceuticals

BLISS GVS PHARMA LTD.

Price Impact